NCT03208504 (NexusSB) is a NA clinical trial of Nexus™ Aortic Arch Stent graft in Thoracic Aortic Diseases, sponsored by Endospan Ltd..

Who is sponsoring NCT03208504?

NCT03208504 is sponsored by Endospan Ltd..

What drugs are being tested in NCT03208504?

Interventions in NCT03208504: Nexus™ Aortic Arch Stent graft.

What condition does NCT03208504 study?

NCT03208504 studies Thoracic Aortic Diseases.

Is NCT03208504 still recruiting?

NCT03208504 is currently completed. Last updated 22 February 2023.

Last reviewed 2023-02-22 · How we verify

NCT03208504: NexusSB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Single Branch NEXUS™ Clinical Study

Completed NA Last updated 22 February 2023

What this trial tests

NA trial testing Nexus™ Aortic Arch Stent graft in Thoracic Aortic Diseases in 1 participant. Completed in 20 January 2023.

Timeline

27 November 2017

Primary endpoint
16 February 2018

20 January 2023

Quick facts

Lead sponsor	Endospan Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	1
Start date	27 November 2017
Primary completion	16 February 2018
Estimated completion	20 January 2023
Sites	1 location across Germany

Drugs / interventions tested

Nexus™ Aortic Arch Stent graft

Conditions studied

Thoracic Aortic Diseases — all drugs for Thoracic Aortic Diseases →

Sponsor

Endospan Ltd.

Who can join

Adults 55 to 90, any sex, with Thoracic Aortic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, open-label, non-randomized, interventional clinical study, sponsored by Endospan Ltd. Subjects will be followed-up for five years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms.
Elhelali A, Hynes N, Devane D, Sultan S, et al · · 2021 · cited 13× · PMID 34085713 · DOI 10.1002/14651858.cd012923.pub2

Verify or expand the search:

Other Endospan Ltd. trials

Trials by the same sponsor.

NCT03420066 — The NEXUS™ Compassionate Use Data Collection Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03208504 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Endospan Ltd.
Last refreshed: 22 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03208504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing